Αποτελέσματα Αναζήτησης
28 Οκτ 2024 · This page lists cancer drugs approved by the Food and Drug Administration (FDA) for breast cancer. The list includes generic and brand names. This page also lists common drug combinations used in breast cancer.
- Alpelisib
Alpelisib - Drugs Approved for Breast Cancer - NCI -...
- Pamidronate Disodium
Definition from the NCI Drug Dictionary - Detailed...
- Tac
Breast cancer. It is often used as adjuvant therapy. This...
- Anastrozole
Anastrozole - Drugs Approved for Breast Cancer - NCI -...
- Femara (Letrozole)
Letrozole is a hormone therapy and targeted therapy drug...
- Ac-T
Use in Cancer. AC-T is used to treat: Breast cancer. This...
- Docetaxel
For Common Form of Bladder Cancer, Chemo Combo Effective...
- Tamoxifen Citrate
Tamoxifen Citrate - Drugs Approved for Breast Cancer - NCI -...
- Alpelisib
7 Απρ 2024 · Find a list of common chemotherapy drugs and drug combinations for early, locally-advanced and metastatic breast cancer.
Although drug combinations are often used to treat early breast cancer, advanced breast cancer often is treated with single chemo drugs. Still, some combinations, such as paclitaxel plus gemcitabine, are commonly used to treat metastatic breast cancer.
20 Αυγ 2024 · Common Types of Chemotherapy for Breast Cancer. Do I need chemo? Choosing a regimen. Side effects. Takeaway. Chemotherapy can sometimes be performed before your surgery (neoadjuvant) or...
Chemotherapy uses anti cancer drugs to destroy cancer cells. It is a common treatment for breast cancer. Find out about how, when and how you have it for breast cancer and about the different drugs and their possible side effects.
Current Personalized Treatments for Breast Cancer: Strengths and Weaknesses. The current strategies of treatment are principally based on the tumor progression and BC molecular subtypes in order to offer the most personalized treatment for BC patients. The algorithm of BC treatment is represented in Figure 2.
20 Μαΐ 2024 · In 2020, ASCO published a guideline on the selection of optimal adjuvant chemotherapy and targeted therapy for breast cancer. 1 This is a rapid recommendation update of that guideline that addresses, in turn, the adjuvant use of the cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors abemaciclib and ribociclib in patients with stage II and III ...